• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

头颈部、泌尿生殖系统及妇科系统神经内分泌肿瘤、原发灶不明肿瘤、甲状旁腺癌及甲状腺内胸腺肿瘤：ESMO临床实践指南之诊断、治疗及随访

Neuroendocrine neoplasms of head and neck, genitourinary and gynaecological systems, unknown primaries, parathyroid carcinomas and intrathyroid thymic neoplasms: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.

作者信息

Hadoux J, Lamarca A, Grande E, Deandreis D, Kaltsas G, Janson E T, Tombal B, Pavel M, Thariat J, van Velthuysen M F, Herman P, Dromain C, Baudin E, Berruti A

机构信息

Département d'Imagerie, Service d'Oncologie Endocrinienne, Gustave Roussy, Villejuif, France.

Department of Oncology, OncoHealth Institute, Fundación Jiménez Díaz University Hospital, Madrid, Spain; Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester; Division of Cancer Sciences, University of Manchester, Manchester, UK.

出版信息

ESMO Open. 2024 Oct;9(10):103664. doi: 10.1016/j.esmoop.2024.103664. Epub 2024 Oct 1.

DOI:10.1016/j.esmoop.2024.103664
PMID:39461777
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11549527/
Abstract

• This Clinical Practice Guideline provides key recommendations for managing rare endocrine tumours. • Neuroendocrine neoplasms of different origins, parathyroid carcinoma and intrathyroid thymic neoplasms are included. • The guideline covers clinical imaging and pathological diagnosis, staging and risk assessment, treatment and follow-up. • The authors comprise a multidisciplinary group of experts from different institutions and countries in Europe. • Recommendations are based on available scientific data and the authors’ collective expert opinion.

摘要

• 本临床实践指南提供了管理罕见内分泌肿瘤的关键建议。

• 涵盖不同起源的神经内分泌肿瘤、甲状旁腺癌和甲状腺内胸腺肿瘤。

• 该指南涵盖临床影像学和病理诊断、分期及风险评估、治疗和随访。

• 作者包括来自欧洲不同机构和国家的多学科专家小组。

• 建议基于现有的科学数据和作者的集体专家意见。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5b9/11549527/898915d35af0/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5b9/11549527/88adfde6e1a7/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5b9/11549527/0e38f14c694e/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5b9/11549527/a9aa2b8ca289/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5b9/11549527/e4a3d945d090/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5b9/11549527/679505066330/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5b9/11549527/6ebb4597d872/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5b9/11549527/898915d35af0/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5b9/11549527/88adfde6e1a7/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5b9/11549527/0e38f14c694e/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5b9/11549527/a9aa2b8ca289/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5b9/11549527/e4a3d945d090/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5b9/11549527/679505066330/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5b9/11549527/6ebb4597d872/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5b9/11549527/898915d35af0/gr7.jpg

相似文献

1
Neuroendocrine neoplasms of head and neck, genitourinary and gynaecological systems, unknown primaries, parathyroid carcinomas and intrathyroid thymic neoplasms: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.头颈部、泌尿生殖系统及妇科系统神经内分泌肿瘤、原发灶不明肿瘤、甲状旁腺癌及甲状腺内胸腺肿瘤：ESMO临床实践指南之诊断、治疗及随访
ESMO Open. 2024 Oct;9(10):103664. doi: 10.1016/j.esmoop.2024.103664. Epub 2024 Oct 1.
2
[Clinicopathological Features of Intrathyroid Thymic Carcinoma].[甲状腺内胸腺癌的临床病理特征]
Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2021 Feb 28;43(1):42-46. doi: 10.3881/j.issn.1000-503X.12609.
3
HPV-associated neuroendocrine carcinomas of the head and neck in FNA biopsies: Clinicopathologic features of a rare entity.头颈部 HPV 相关神经内分泌癌的细针穿刺活检：一种罕见实体的临床病理特征。
Cancer Cytopathol. 2019 Feb;127(1):26-34. doi: 10.1002/cncy.22075. Epub 2018 Nov 26.
4
Pan-Asian adaptation of the EHNS-ESMO-ESTRO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with squamous cell carcinoma of the head and neck.泛亚地区适用的 EHNS-ESMO-ESTRO 临床实践指南：头颈部鳞状细胞癌的诊断、治疗和随访。
ESMO Open. 2021 Dec;6(6):100309. doi: 10.1016/j.esmoop.2021.100309. Epub 2021 Nov 26.
5
Usefulness of preoperative ultrasonographic localization for diagnosis of a rare disease: Intrathyroid parathyroid lesions.术前超声定位对罕见疾病——甲状腺内甲状旁腺病变诊断的实用性
Medicine (Baltimore). 2018 Jun;97(23):e10999. doi: 10.1097/MD.0000000000010999.
6
Neuroendocrine thymic carcinoma metastatic to the parathyroid gland that was reimplanted into the forearm in patient with multiple endocrine neoplasia type 1 syndrome: a challenging management dilemma.神经内分泌性胸腺癌转移至甲状旁腺癌，在 1 型多发性内分泌肿瘤综合征患者中被重新植入前臂：具有挑战性的管理难题。
Endocr Pract. 2013 Nov-Dec;19(6):e163-7. doi: 10.4158/EP13267.CR.
7
Utility of monoclonal PAX8 antibody for distinguishing intrathyroid thymic carcinoma from follicular cell-derived thyroid carcinoma.单克隆PAX8抗体在鉴别甲状腺内胸腺癌与滤泡细胞源性甲状腺癌中的应用
Endocr J. 2018 Dec 28;65(12):1171-1175. doi: 10.1507/endocrj.EJ18-0282. Epub 2018 Sep 12.
8
Hyperfunctioning intrathyroid parathyroid gland: a potential cause of failure in parathyroidectomy.甲状腺内甲状旁腺功能亢进：甲状旁腺切除术中失败的一个潜在原因。
Surgery. 2006 Jun;139(6):821-6. doi: 10.1016/j.surg.2005.11.009.
9
Islet-1 Is Differentially Expressed Among Neuroendocrine and Non-Neuroendocrine Tumors and Its Potential Diagnostic Implication.胰岛-1在神经内分泌肿瘤和非神经内分泌肿瘤中的表达存在差异及其潜在诊断意义。
Int J Surg Pathol. 2023 Oct;31(7):1294-1301. doi: 10.1177/10668969231157319. Epub 2023 Feb 21.
10
Renal cell carcinoma: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.肾细胞癌：ESMO 诊断、治疗及随访临床实践指南
Ann Oncol. 2024 Aug;35(8):692-706. doi: 10.1016/j.annonc.2024.05.537. Epub 2024 May 22.

引用本文的文献

1
A Case of Micro-medullary Thyroid Carcinoma Presenting as Cancer of Unknown Primary.一例表现为原发灶不明癌的微小髓样甲状腺癌病例。
Cureus. 2025 Jul 1;17(7):e87085. doi: 10.7759/cureus.87085. eCollection 2025 Jul.
2
Rare Head and Neck Neuroendocrine Neoplasms: A Retrospective Study of Prognosis and Treatment Outcomes.罕见头颈部神经内分泌肿瘤：预后与治疗结果的回顾性研究
Cancer Diagn Progn. 2025 Jun 30;5(4):469-477. doi: 10.21873/cdp.10460. eCollection 2025 Jul-Aug.
3
Precision Oncology in Rare Endocrine and Neuroendocrine Neoplasms: Experiences and Challenges of the CCCMunich Molecular Tumor Board.

本文引用的文献

1
Treatment and outcome of metastatic parathyroid carcinoma: A systematic review and pooled analysis of published cases.转移性甲状旁腺癌的治疗与转归：已发表病例的系统评价与汇总分析
Front Oncol. 2022 Sep 26;12:997009. doi: 10.3389/fonc.2022.997009. eCollection 2022.
2
European Neuroendocrine Tumor Society (ENETS) 2022 Guidance Paper for Carcinoid Syndrome and Carcinoid Heart Disease.欧洲神经内分泌肿瘤学会（ENETS）2022年类癌综合征和类癌心脏病指南文件。
J Neuroendocrinol. 2022 Jul;34(7):e13146. doi: 10.1111/jne.13146. Epub 2022 May 25.
3
Update from the 5th Edition of the World Health Organization Classification of Head and Neck Tumors: Overview of the 2022 WHO Classification of Head and Neck Neuroendocrine Neoplasms.
罕见内分泌和神经内分泌肿瘤的精准肿瘤学：慕尼黑CCCM分子肿瘤委员会的经验与挑战
Target Oncol. 2025 Jun 30. doi: 10.1007/s11523-025-01152-6.
4
Peri-renal metastasis of cervical neuroendocrine carcinoma: a case report and literature review.宫颈神经内分泌癌肾周转移：1例报告并文献复习
J Surg Case Rep. 2025 Jun 13;2025(6):rjaf412. doi: 10.1093/jscr/rjaf412. eCollection 2025 Jun.
第五版世界卫生组织头颈部肿瘤分类更新：2022 年世界卫生组织头颈部神经内分泌肿瘤分类概述。
Head Neck Pathol. 2022 Mar;16(1):123-142. doi: 10.1007/s12105-022-01435-8. Epub 2022 Mar 21.
4
Overview of the 2022 WHO Classification of Neuroendocrine Neoplasms.《2022 年世卫组织神经内分泌肿瘤分类概述》。
Endocr Pathol. 2022 Mar;33(1):115-154. doi: 10.1007/s12022-022-09708-2. Epub 2022 Mar 16.
5
Overview of the 2022 WHO Classification of Parathyroid Tumors.《2022 年世卫组织甲状旁腺肿瘤分类概述》。
Endocr Pathol. 2022 Mar;33(1):64-89. doi: 10.1007/s12022-022-09709-1. Epub 2022 Feb 17.
6
ENETS standardized (synoptic) reporting for neuroendocrine tumour pathology.神经内分泌肿瘤病理学的ENETS标准化（概要）报告
J Neuroendocrinol. 2022 Mar;34(3):e13100. doi: 10.1111/jne.13100. Epub 2022 Feb 14.
7
Safety and diagnostic performance of parathyroid hormone assay in fine-needle aspirate in suspicious parathyroid adenomas.在可疑甲状旁腺瘤的细针抽吸中甲状旁腺激素检测的安全性和诊断性能。
Endocrinol Diabetes Nutr (Engl Ed). 2021 Aug-Sep;68(7):481-488. doi: 10.1016/j.endien.2020.07.004. Epub 2021 Nov 24.
8
Intrasalivary Thymic Carcinoma: A Case Report and Literature Review.涎腺胸腺癌：病例报告及文献复习。
Head Neck Pathol. 2022 Sep;16(3):857-864. doi: 10.1007/s12105-021-01394-6. Epub 2021 Nov 22.
9
Lu-Dotatate plus long-acting octreotide versus high‑dose long-acting octreotide in patients with midgut neuroendocrine tumours (NETTER-1): final overall survival and long-term safety results from an open-label, randomised, controlled, phase 3 trial.Lu-Dotatate 联合长效奥曲肽与高剂量长效奥曲肽治疗肠神经内分泌肿瘤患者（NETTER-1）：一项开放标签、随机、对照、III 期临床试验的最终总生存和长期安全性结果。
Lancet Oncol. 2021 Dec;22(12):1752-1763. doi: 10.1016/S1470-2045(21)00572-6. Epub 2021 Nov 15.
10
Multicenter Analysis of Presacral Neuroendocrine Neoplasms-Clinicopathological Characterization and Treatment Outcomes of a Rare Disease.骶前神经内分泌肿瘤的多中心分析：一种罕见疾病的临床病理特征和治疗结果。
Front Endocrinol (Lausanne). 2021 Oct 6;12:709256. doi: 10.3389/fendo.2021.709256. eCollection 2021.